ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Pay raise Must Come From Intramural Funds, Not Extramural, Administration Says

May 9, 1980

Cancer researchers support “responsible” human stem cell research.

July 22, 2005

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

April 15, 1977

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007

NCI Review Groups Merged Into One Umbrella Group

November 17, 1995

In Brief: Calabresi: Rimer: Outstanding ”For NCAB Chair; board Should Maintain Strong Leadership Role

September 23, 1994